In Nigeria only 35% of births are attended by a skilled health provider. Women who deliver without a skilled provider have an increased risk of dying in childbirth, most frequently from postpartum hemorrhage (PPH), the leading cause of maternal death. In the case of Nigeria, the risks to mothers are high; a Nigerian woman has a 1 in 18 lifetime risk of maternal death. Fifty nine thousand (59,000) Nigerian women die from pregnancy related causes each year.
To save mothers’ lives by preventing postpartum hemorrhage in home births with misoprostol tablets for women who are unable to reach a facility to deliver.
The Population and Reproductive Health Partnership (PRHP) of Ahmadu Bello University, Zaria, Nigeria, collaborated with the Bixby Center and Venture Strategies Innovations (VSI) on a study to provide empirical evidence to inform policy decision-makers on the safety of misoprostol administered by traditional birth attendants (TBAs) at home births to prevent postpartum hemorrhage.
The study was cross-sectional and descriptive in design and sought to describe community-level distribution, knowledge, acceptance and uptake of misoprostol at home births in five communities (Unguwan Godo and Hayin Ojo in Sabon Gari Local Government Area (LGA), Dakace in Zaria LGA, and Tsibiri and Yakawada in Giwa LGA).
The study includes community awareness campaigns about birth preparedness and the prevention of postpartum hemorrhage, as well as misoprostol distribution through drug keepers, TBAs and community-oriented resource persons.
The specific objectives include:
Based upon the available data, the study concluded that misoprostol at the community level is a feasible, safe, effective, and acceptable intervention by the community.
Download the policy brief: Prevention of Postpartum Hemorrhage at Home Births in Five Communities around Zaria, Kaduna State, Nigeria